Tyrosine Protein Kinase Receptor Market Size | COVID-19 Impact Analysis | Forecast to 2027

The global tyrosine protein kinase receptor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Receptor tyrosine kinases (RTKs) are high-affinity cell surface receptors for many polypeptide growth factors such as cytokines and hormones. Additionally, these receptors are activated by the ligands that is binding them to their extracellular domain. The major factor accelerating the growth of the market is the increasing prevalence of cancer across the globe.

According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases in 2018 which is anticipated to rise to 29.5 million by 2040. Hence, the rising prevalence of cancer is supporting the demand for tyrosine kinase receptors which in turn is driving the growth of the market.

To Request a Sample of our Report on Tyrosine Protein Kinase Receptor Market:  https://www.omrglobal.com/request-sample/tyrosine-protein-kinase-receptor-market

Some major players in the market include Bayer AG, Boehringer Ingelheim International, and AstraZeneca plc among others. Moreover, based on type, the market is segmented into epidermal growth factor receptor (EGFR)-, vascular endothelial growth factor receptor (VEGFR)-, platelet-derived growth factor receptor (PDGFR) – tyrosine kinase inhibitors, and others. VEGFR-TKIs is expected to hold a prominent share in the market owing to its application in the treatment of lung cancer, which is the most common type of cancer globally.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027

Segment Covered- 

  • By Type
  • By Application

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- Bayer AG, Boehringer Ingelheim International, and AstraZeneca plc among others.

(Get 15% Discount on Buying this Report)

A full Report of Tyrosine Protein Kinase Receptor Market is Available @  https://www.omrglobal.com/industry-reports/tyrosine-protein-kinase-receptor-market

Global Tyrosine Protein Kinase Receptor Market Report by Segment

By Type

  • Epidermal Growth Factor Receptor (EGFR)
  • Vascular Endothelial Growth Factor Receptor (VEGFR)
  • Platelet-Derived Growth Factor Receptor (PDGFR)
  • Others

By Application 

  • Lung Cancer
  • Breast Cancer
  • Renal Cell Cancer
  • Others

Global Tyrosine Protein Kinase Receptor Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East & Africa

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404